PRESS RELEASE published on 08/04/2025 at 08:30, 10 months 19 days ago Oxurion rondt overname van Axiodis CRO af en versnelt uitbouw van haar Europese platform voor klinische data Oxurion schliesst erfolgreich die Übernahme von 72% des Aktienkapitals von Axiodis CRO ab und beschleunigt die Gespräche mit strategischen Partnern zur Schaffung eines integrierten Plattforms für klinische Daten Übernahme Partnerschaften Oxurion Axiodis CRO Klinische Daten
BRIEF published on 07/30/2025 at 18:05, 10 months 23 days ago Oxurion Réceptionne une Notification de Transparence Modifiée Actions Transparence Atlas Special Opportunities Oxurion Bio-pharmaceutique
BRIEF published on 07/30/2025 at 18:05, 10 months 23 days ago Oxurion Receives a Modified Transparency Notification Actions Transparency Biopharmaceutical Atlas Special Opportunities Oxurion
PRESS RELEASE published on 07/30/2025 at 18:00, 10 months 23 days ago Oxurion ontvangt aangepaste transparantiekennisgeving van Atlas Special Opportunities II LLC Oxurion NV receives transparency notification from Atlas Special Opportunities II LLC regarding shareholding threshold Transparency Notification Shareholding Belgium Oxurion NV Atlas Special Opportunities II LLC
PRESS RELEASE published on 07/30/2025 at 18:00, 10 months 23 days ago Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV announces receipt of transparency notification on shareholder ownership crossing under threshold due to selling of voting securities. Press release replaces previous announcement Transparency Notification Biopharmaceutical Oxurion NV Voting Securities Shareholder Ownership
BRIEF published on 07/25/2025 at 18:05, 10 months 28 days ago Oxurion Annonce une Augmentation de Capital via Conversion d'Obligations Augmentation De Capital Biopharmaceutique Actions Ordinaires Atlas Special Opportunities Oxurion
BRIEF published on 07/25/2025 at 18:05, 10 months 28 days ago Oxurion Announces Capital Increase via Bond Conversion Common Shares Capital Increase Biopharmaceuticals Atlas Special Opportunities Oxurion
PRESS RELEASE published on 07/25/2025 at 18:00, 10 months 28 days ago Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie Atlas Special Opportunities, LLC convertit 10 obligations convertibles en Oxurion, augmentant le capital de 250 000 EUR. Oxurion reçoit 11 161 618 nouvelles actions pour 250 000 EUR dans le cadre de l'engagement de 20 millions EUR d'Atlas Innovation Capital Atlas Special Opportunities Oxurion Convertissement
PRESS RELEASE published on 07/25/2025 at 18:00, 10 months 28 days ago Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas Atlas Special Opportunities, LLC converts 10 convertible bonds in Oxurion, resulting in a EUR 250,000 capital increase. Oxurion continues focus on innovative therapeutics for elderly vision preservation Capital Increase Therapeutics Atlas Special Opportunities Oxurion Vision Preservation
BRIEF published on 07/24/2025 at 18:05, 10 months 29 days ago Augmentation du capital d'Oxurion suite à une conversion d'obligations Capital Biotechnologie Actions Atlas Oxurion
Published on 06/23/2026 at 09:05, 2 hours 18 minutes ago Star Copper Extends Copper Creek Drill Hole Beyond Planned Depth After Intersecting Mineralized System
Published on 06/23/2026 at 06:45, 4 hours 38 minutes ago CTO Confidence in Scaling AI Falls for Third Straight Year, Akkodis Report Finds
Published on 06/23/2026 at 06:45, 4 hours 38 minutes ago La confiance des CTO dans le déploiement à grande échelle de l'IA recule pour la troisième année consécutive
Published on 06/23/2026 at 06:01, 5 hours 22 minutes ago Star Copper Extends Copper Creek Drill Hole Beyond Planned Depth After Intersecting Mineralized System
Published on 06/23/2026 at 01:55, 9 hours 28 minutes ago Ameriwest Launches Bornite Community and Stakeholder Engagement Program
Published on 06/23/2026 at 11:05, 17 minutes ago FamiCord AG wins ArThec as another customer in its CDMO business area
Published on 06/23/2026 at 10:54, 28 minutes ago EQS-Adhoc: Voltatron Wins Major Contract to Supply Electronics Solutions for Industrial Electromobility
Published on 06/23/2026 at 10:46, 36 minutes ago Rixos Expands Hurghada Presence with Opening of Rixos Premium Magawish Bay View
Published on 06/23/2026 at 10:45, 38 minutes ago Edison issues report on Partners Group Private Equity (PEY)
Published on 06/23/2026 at 10:44, 39 minutes ago World Bronchiectasis Conference 2026 kicks off: Driving Progress for Patients Worldwide
Published on 06/22/2026 at 18:00, 17 hours 23 minutes ago GUILLEMOT CORPORATION : DECES DE M. CLAUDE GUILLEMOT, Président du Groupe GUILLEMOT CORPORATION